Akums Drugs IPO GMP Today, Grey Market Premium 2024
Find out the latest list of today’s Akums Drugs IPO GMP or IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates. Pending the commencement of IPO GMP of Akums Drugs, it has not been recorded yet. This is your cue for the most updated list of Akums Drugs IPO GMP rates.
Akums Drugs IPO GMP Important Dates
Open: July 30, 2024
Close: August 1, 2024
Allotment: August 2, 2024
Listing: August 6, 2024
Akums Drugs IPO and GMP Details
Akums Drugs and Pharmaceuticals is going to come out with its IPO on July 30, 2024, with an aim to mobilize ₹1,856. 74 crores. It is said that the shares are going to be offered at a price band of ₹646 to ₹679 per equity share and in lots of 22 shares. Akums was set up in 2004 and is a leader in the sphere of pharmaceutical contract development and manufacturing. This company can boast of vast experience in product innovation and production; it owns some strategic patents. They have operations in different parts of the world that affirm them as a leading end-to-end solutions company in the pharma segment.
Table of Contents
Akums Drugs IPO GMP Day by Day
| Date | IPO GMP | Kostak | Subject to |
|---|---|---|---|
| Today | ₹150 | ₹- | ₹- |
| 25 July | ₹150 | ₹- | ₹- |
| 24 July | ₹150 | ₹- | ₹- |
Akums Drugs IPO GMP (Grey Market Premium) FAQs:
– The Grey Market Premium (GMP) for Akums Drugs IPO today is ₹150.
– The Kostak Rate for Drugs IPO currently stands at ₹-.
– The subject to sauda rates for Akums Drugs IPO are at an impressive ₹-.
– The Drugs IPO is expected to yield a robust return of 21%.
IPO Watch GMP means Initial Public Offering Grey Market Premium(IPO GMP).
Chittorgarh IPO GMP means Initial Public Offering Grey Market Premium(IPO GMP).
IPO GMP Today available on www.ipodekh.com
Akums Drugs IPO GMP is ₹150
Disclaimer*
– IPO Dekh is not buying and selling IPO forms on IPO Grey Market.
– Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
– Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
